GlassScriptPhysician profile
Marvi Bikak
NPI 1548600380
$27,668.42
in general payments reported to CMS, 2019-2025
33 companies · $5,114 in 2025
The $5,114 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $216 · 2021: $1,626 · 2022: $2,031 · 2023: $1,084 · 2024: $18K · 2025: $5,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $5,783 · Travel and Lodging: $2,759 · Education: $2,109 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,130.00 |
| Food and Beverage | $5,782.92 |
| Travel and Lodging | $2,758.74 |
| Education | $2,109.25 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $15,452.95 | 2020-2025 | Fasenra, Tezspire, Airsupra |
| Intuitive Surgical, INC. | $5,189.24 | 2024 | |
| Glaxosmithkline, LLC. | $1,472.21 | 2020-2025 | Nucala, Trelegy Ellipta |
| Jazz Pharmaceuticals INC. | $555.84 | 2021-2025 | |
| Inspire Medical Systems, INC. | $431.95 | 2021-2025 | Inspire |
| Mylan Specialty L.P. | $375.31 | 2021-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $356.83 | 2020-2025 | Ofev, Jascayd |
| Harmony Biosciences LLC | $351.75 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $329.98 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $312.96 | 2022-2025 | |
| Electromed, INC. | $311.77 | 2021-2024 | Smartvest |
| Amgen INC. | $288.99 | 2022-2025 | Tezspire, Tavneos |
| Baxter Healthcare | $270.67 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Mallinckrodt Hospital Products INC. | $221.83 | 2021-2025 | Acthar |
| Janssen Pharmaceuticals, INC | $205.38 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $195.58 | 2022-2025 | |
| Viatris Specialty LLC | $167.82 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $163.43 | 2020-2025 | Glassia, Entyvio |
| Grifols USA, LLC | $157.34 | 2021-2024 | Prolastin-C Liquid |
| Verona Pharma, INC. | $150.65 | 2025 | Ohtuvayre |
| Avadel Cns Pharmaceuticals, LLC | $138.79 | 2024-2025 | Lumryz |
| Regeneron Healthcare Solutions, INC. | $127.09 | 2022-2025 | Dupixent |
| Itamar Medical INC | $68.24 | 2023-2025 | Watchpatone |
| Abbvie INC. | $52.10 | 2023-2025 | Teflaro, Dalvance |
| Sunovion Pharmaceuticals INC. | $51.32 | 2021 | |
| Advanced Respiratory, INC | $50.97 | 2021 | |
| Inari Medical, INC. | $44.80 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $43.50 | 2022-2025 | Patient Interface Software |
| Janssen Biotech, INC. | $36.59 | 2024 | Stelara |
| Insmed, INC. | $30.94 | 2025 | Arikayce, Brinsupri |
| Mayne Pharma Commercial LLC | $27.42 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $20.85 | 2021 | |
| Genentech USA, INC. | $13.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvi Bikak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.